The most frequently reported TEAEs (≥ 1%) were hyperkalemia/blood potassium increase (25 participants; 5.0%), urinary tract infection (six participants; 1.2%, three of whom were documented to be on an SGLT2 inhibitor at the time of the event), vitamin D deficiency (six participants; 1.2%), acute kidney injury (five participants; 1%), and coronavirus disease 2019 (five participants; 1%) (Table 2). The gene discussed is SLC5A2; the disease is COVID-19.